Literature DB >> 18159517

Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility.

Cheryl L Main1, Padman Jayaratne, Allan Haley, Candy Rutherford, Fiona Smaill, David N Fisman.   

Abstract

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) has been identified in prison settings in the United States. The present study investigated two clusters of skin and soft tissue infection caused by community-acquired (CA) MRSA in a correctional facility in southern Ontario.
METHODS: Outbreak investigations were conducted by the responsible public health authority. Strain relatedness was assessed through comparison of pulsed-field gel electrophoresis and antibiograms.
RESULTS: Two distinct outbreaks of CAMRSA-associated disease occurred in 2002 and 2004. Most patients presented with abscesses in the lower extremities. All isolates had identical DNA banding patterns on pulsed-field gel electrophoresis. One-half of the affected inmates resided in a cellblock with one other affected inmate. No other risk factors were identified.
CONCLUSIONS: One of the first outbreaks of CAMRSA infections in a correctional facility in Canada is documented. Taken in conjunction with outbreaks elsewhere, this suggests that residence in correctional facilities may be a risk factor for CAMRSA infection.

Entities:  

Keywords:  Canada; Community-acquired MRSA; Correctional facility; Panton-Valentine leukocidin

Year:  2005        PMID: 18159517      PMCID: PMC2094999          DOI: 10.1155/2005/698181

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  32 in total

1.  Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis.

Authors:  M R Mulvey; L Chui; J Ismail; L Louie; C Murphy; N Chang; M Alfa
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Hospital-acquired and community-derived: the future of MRSA?

Authors:  Bo Shopsin; Sharon Herring; Barry N Kreiswirth
Journal:  Clin Infect Dis       Date:  2003-07-01       Impact factor: 9.079

3.  Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails.

Authors:  Erica S Pan; Binh A Diep; Heather A Carleton; Edwin D Charlebois; George F Sensabaugh; Barbara L Haller; Françoise Perdreau-Remington
Journal:  Clin Infect Dis       Date:  2003-10-17       Impact factor: 9.079

4.  Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community.

Authors:  Keiko Okuma; Kozue Iwakawa; John D Turnidge; Warren B Grubb; Jan M Bell; Frances G O'Brien; Geoffrey W Coombs; John W Pearman; Fred C Tenover; Maria Kapi; Chuntima Tiensasitorn; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

6.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

7.  Detection of methicillin-resistant Staphylococcus aureus (MRSA) from growth on mannitol salt oxacillin agar using PCR for nosocomial surveillance.

Authors:  P Jayaratne; C Rutherford
Journal:  Diagn Microbiol Infect Dis       Date:  1999-09       Impact factor: 2.803

8.  Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin.

Authors:  Philippe Dufour; Yves Gillet; Michèle Bes; Gerard Lina; François Vandenesch; Daniel Floret; Jerome Etienne; Hervé Richet
Journal:  Clin Infect Dis       Date:  2002-09-03       Impact factor: 9.079

9.  Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska.

Authors:  Henry C Baggett; Thomas W Hennessy; Karen Rudolph; Dana Bruden; Alisa Reasonover; Alan Parkinson; Rachel Sparks; Rodney M Donlan; Patricia Martinez; Kanokporn Mongkolrattanothai; Jay C Butler
Journal:  J Infect Dis       Date:  2004-04-16       Impact factor: 5.226

10.  Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin.

Authors:  Binh An Diep; George F Sensabaugh; Naraporn Somboonna; Naraporn S Somboona; Heather A Carleton; Françoise Perdreau-Remington
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

View more
  19 in total

1.  Risk factors for infection and colonization with community-associated methicillin-resistant Staphylococcus aureus in the Los Angeles County jail: a case-control study.

Authors:  Cynthia L Maree; Samantha J Eells; Jennifer Tan; Elizabeth A Bancroft; Mark Malek; Nina T Harawa; Martha J Lewis; Elaine Santana; Loren G Miller
Journal:  Clin Infect Dis       Date:  2010-10-29       Impact factor: 9.079

2.  Community-acquired MRSA: a practitioner's guide.

Authors:  Lindsay Nicolle
Journal:  CMAJ       Date:  2006-06-27       Impact factor: 8.262

Review 3.  Evidence-based approach to abscess management.

Authors:  Christina Korownyk; G Michael Allan
Journal:  Can Fam Physician       Date:  2007-10       Impact factor: 3.275

4.  A sentinel fatal paediatric case of community-associated methicillin-resistant Staphylococcus aureus in Canada.

Authors:  Jason Brophy; Yvonne Yau; Peter Cox; Kevin Katz; Ari Bitnun
Journal:  Paediatr Child Health       Date:  2007-04       Impact factor: 2.253

5.  Long-term follow-up of methicillin-resistant Staphylococcus aureus molecular epidemiology after emergence of clone USA300 in San Francisco jail populations.

Authors:  Pierre Tattevin; Binh An Diep; Michael Jula; Françoise Perdreau-Remington
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

6.  Prevalence of methicillin-resistant Staphylococcus aureus in a Canadian inner-city shelter.

Authors:  Tom A Szakacs; Baldwin Toye; Jeffrey M Turnbull; Wendy Muckle; Virginia R Roth
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

7.  A nosocomial outbreak of community-associated methicillin-resistant Staphylococcus aureus among healthy newborns and postpartum mothers.

Authors:  Andrea Saunders; Linda Panaro; Allison McGeer; Alana Rosenthal; Diane White; Barbara M Willey; Denise Gravel; Erika Bontovics; Barbara Yaffe; Kevin Katz
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-03       Impact factor: 2.471

8.  Hand and nasal carriage of discordant Staphylococcus aureus isolates among urban jail detainees.

Authors:  Michael Z David; Jane D Siegel; Janet Henderson; Greg Leos; Kaming Lo; Jerry Iwuora; Alexis R Taylor; Diana L Zychowski; Esmaeil Porsa; Susan Boyle-Vavra; Robert S Daum
Journal:  J Clin Microbiol       Date:  2014-06-23       Impact factor: 5.948

9.  Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners.

Authors:  Michelle Barton; Michael Hawkes; Dorothy Moore; John Conly; Lindsay Nicolle; Upton Allen; Nora Boyd; Joanne Embree; Liz Van Horne; Nicole Le Saux; Susan Richardson; Aideen Moore; Dat Tran; Valerie Waters; Mary Vearncombe; Kevin Katz; J Scott Weese; John Embil; Marianna Ofner-Agostini; E Lee Ford-Jones
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

10.  The human nasal microbiota and Staphylococcus aureus carriage.

Authors:  Daniel N Frank; Leah M Feazel; Mary T Bessesen; Connie S Price; Edward N Janoff; Norman R Pace
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.